Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Wyatt, J., Vogelsang, H., Hubl, W., Waldhoer, T
ISBN 978-1-62429-391-7
Elevated beta-glucuronidase activity has been associated with an increased risk for various hormone-dependent cancers such as breast, colon, and prostate cancers
$ 62.800 PUM: $ 2,990.48 BOL $ 59.450 PUM: $ 1,189.00 BOL $ 35.700 PUM: $ 89.25 ml $ 216.200 PUM: $ 72,066.67 BOL $ 39.800 PUM: $ 53.06 ml $ 17.500 PUM: $ 5,833.33 BAR $ 77.400 UM: $ 1,290.00 TAB $ 151.800 PUM: $ 178.58 g HALEON COLOMBIA SAS $ 85.900 PUM: $ 477.22 g $ 30.240 PUM: $ 560.00 GOM $ 29.700 PUM: $ 90.00 g ABBOTT LABORATORIES DE COLOMBI $ 78.060 PUM: $ 2,602.00 ml LAFRANCOL S.A.S $ 45.920 PUM: $ 71.75 g OPELLA HEALTHCARE COLOMBIA SAS $ 18.320 PUM: $ 1,908.33 TAB $14.520 PUM: $ 3,025.00 SOB GALDERMA DE COLOMBIA S A $ 10.200 PUM: $ 2,125.00 TAB PROCAPS S.A S A $85.840 PUM: $ 2,146.00 ml BAYER S.A $ 56.482 PUM: $ 6,805.00 TAB PROCTER & GAMBLE COLOMBIA
In the 2024 guidelines published by the ESC for PAD management, the authors do not mention GLP-1 RAs as part of management, likely due to limited data at the time [50]
